Success Stories: Botulinum Toxin Treatment Program

This program has been in operation for over 10 years. More than 600 patients have been treated and over 1000 treatments have been given. No serious side effects have been reported. Many patients have benefited from the interventions.

Kennedy Krieger Institute Announces Retirement of President and CEO

Dr. Gary W. GoldsteinThe Institute’s board of directors is conducting a national search and is expected to name a new CEO in the coming months.
Learn more.

Appointments & Referrals



Read inspiring stories, news and updates about the Institute's patient care, research, special education, professional training, and community programs.


Resource Finder


A free resource that provides access to information and support for individuals and families living with developmental disabilities.